{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:56:16Z","timestamp":1756810576473},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Public Health Pol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1057\/s41271-020-00266-7","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T08:03:15Z","timestamp":1606896195000},"page":"6-14","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["COVID-19, host response treatment, and the need for political leadership"],"prefix":"10.1057","volume":"42","author":[{"given":"David S.","family":"Fedson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,2]]},"reference":[{"key":"266_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.amjcard.2005.04.029","volume":"96","author":"GC Fonarow","year":"2005","unstructured":"Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol. 2005;96:611\u20136.","journal-title":"Am J Cardiol"},{"key":"266_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.21037\/atm.2016.11.03","volume":"4","author":"DS Fedson","year":"2016","unstructured":"Fedson DS. Treating the host response to emerging virus diseases: lesson learned from sepsis, pneumonia, influenza and Ebola. Ann Transl Med. 2016;4:421.","journal-title":"Ann Transl Med"},{"key":"266_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875\u20139. https:\/\/doi.org\/10.1038\/nm1267.","journal-title":"Nat Med"},{"key":"266_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112\u20136. https:\/\/doi.org\/10.1038\/nature03712.","journal-title":"Nature"},{"key":"266_CR5","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/path.2987","volume":"25","author":"RM W\u00f6sten-van Asperen","year":"2011","unstructured":"W\u00f6sten-van Asperen RM, Lutter R, Specht PA, Moll GN, van Woensel JB, van der Loos CM, et al. Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1\u20137) or an angiotensin II receptor antagonist. J Pathol. 2011;25:618\u201327. https:\/\/doi.org\/10.1002\/path.2987.","journal-title":"J Pathol"},{"key":"266_CR6","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/ATVBAHA.120.314558","volume":"40","author":"D Gustafson","year":"2020","unstructured":"Gustafson D, Raju S, Wu R, Ching C, Veitch S, Rathnakumar K, et al. Overcoming barriers: the endothelium as a linchpin of coronavirus disease 2019 pathogenesis? Arterioscler Thromb Vasc Biol. 2020;40:1818\u201329. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314558.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"266_CR7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of Covid-19 - Final report. N Engl J Med. 2020; 383:1813\u201326. https:\/\/doi.org\/10.1056\/NEJMoa2007764.","journal-title":"N Engl J Med"},{"key":"266_CR8","doi-asserted-by":"publisher","unstructured":"Xia X,\u00a0Li K, Wu L,\u00a0Wang Z,\u00a0Zhu M, Huang B,\u00a0et al. Improved clinical symptoms and mortality on severe\/critical COVID-19 patients utilizing convalescent plasma transfusion. Blood.\u00a02020;136:755\u20139.;126:1671\u201381 doi: https:\/\/doi.org\/10.1182\/blood.2020007079.","DOI":"10.1182\/blood.2020007079"},{"key":"266_CR9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","author":"P Horby","year":"2020","unstructured":"RECOVERY Collaborative Group, Horby P, Lim WS, Emberson J, Mafham M, Bell J, et al. Dexamethasone in hospitalized patients with Covid-19: preliminary report. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2021436.","journal-title":"N Engl J Med"},{"key":"266_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R Wofel","year":"2020","unstructured":"Wofel R, Corman VM, Guggemos W, Seilmaier M, Zange S, M\u00fcller MA, et al. Virological assessment of hospitalized patients with COVID-19. Nature. 2020;581:465\u20139. https:\/\/doi.org\/10.1038\/s41586-020-2196-x.","journal-title":"Nature"},{"key":"266_CR11","doi-asserted-by":"publisher","first-page":"e00398","DOI":"10.1128\/mBio.00398-20","volume":"11","author":"DS Fedson","year":"2020","unstructured":"Fedson DS, Opal SM, Rordam OM. Hiding in plain sight; an approach to treating patients with severe COVID-19 infection. mBio. 2020;11:e00398-e420. https:\/\/doi.org\/10.1128\/mBio.00398-20.","journal-title":"mBio"},{"key":"266_CR12","doi-asserted-by":"publisher","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","volume":"318","author":"AM South","year":"2020","unstructured":"South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol. 2020;318:H1084\u201390. https:\/\/doi.org\/10.1152\/ajpheart.00217.2020.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"266_CR13","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","volume":"126","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, et al. Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020;126:1671\u201381. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317134.","journal-title":"Circ Res"},{"key":"266_CR14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/ejhf.1924","volume":"22","author":"D Bean","year":"2020","unstructured":"Bean D, Kralijevic Z, Searle T, Bendayan R, O\u2019Gallagher K, Pickles A, et al. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust. Eur J Heart Fail. 2020;22:967\u201374. https:\/\/doi.org\/10.1002\/ejhf.1924.","journal-title":"Eur J Heart Fail"},{"key":"266_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","volume":"32","author":"XJ Zhang","year":"2020","unstructured":"Zhang XJ, Qin JJ, Cheng X, Shen L, Zhao YC, Yuan Y, et al. In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19. Cell Metab. 2020;32:176\u201387. https:\/\/doi.org\/10.1016\/j.cmet.2020.06.015.","journal-title":"Cell Metab"},{"issue":"1","key":"266_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/emph\/eoy027","volume":"2018","author":"DS Fedson","year":"2018","unstructured":"Fedson DS. Influenza, evolution, and the next pandemic. Evol Med Public Health. 2018;2018(1):260\u20139. https:\/\/doi.org\/10.1093\/emph\/eoy027.","journal-title":"Evol Med Public Health"},{"key":"266_CR17","doi-asserted-by":"publisher","first-page":"902","DOI":"10.15252\/embr.201540637","volume":"16","author":"M Baddeley","year":"2015","unstructured":"Baddeley M. Herding, social influences and behavioural bias in scientific research. EMBO Rep. 2015;16:902\u20135. https:\/\/doi.org\/10.15252\/embr.201540637.","journal-title":"EMBO Rep"},{"key":"266_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S1473-3099(08)70070-7","volume":"8","author":"DS Fedson","year":"2008","unstructured":"Fedson DS. Confronting an influenza pandemic with inexpensive generic agents: can it be done? Lancet Infect Dis. 2008;8:571\u20136. https:\/\/doi.org\/10.1016\/S1473-3099(08)70070-7.","journal-title":"Lancet Infect Dis"},{"key":"266_CR19","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1056\/NEJMsb1209510","volume":"368","author":"N Lurie","year":"2013","unstructured":"Lurie N, Manolio T, Patterson AP, Collins F, Frieden T. Research as a part of public health emergency response. N Engl J Med. 2013;368:1251\u20135. https:\/\/doi.org\/10.1056\/NEJMsb1209510.","journal-title":"N Engl J Med"},{"key":"266_CR20","unstructured":"Ignatieff M. Getting Iraq wrong. New York Times Sunday Magazine. August 5, (2007)."},{"key":"266_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.7326\/0003-4819-145-2-200607180-00132","volume":"145","author":"I Starr","year":"2006","unstructured":"Starr I. Influenza in 1918: recollections of the epidemic in Philadelphia 1976. Ann Intern Med. 2006;145:138\u201340.","journal-title":"Ann Intern Med."},{"key":"266_CR22","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1111\/jth.15004","volume":"18","author":"J Thachil","year":"2020","unstructured":"Thachil J, Juffermans NP, Ranucci M, Connors JM, Warkentin TE, Ortel TL, et al. ISTH DIC subcommittee communication on anticoagulation in COVID-19. J Thromb Haemos. 2020;18:2138\u201344. https:\/\/doi.org\/10.1111\/jth.15004.","journal-title":"J Thromb Haemos"},{"key":"266_CR23","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1016\/S1473-3099(20)30123-7","volume":"20","author":"S Simpson","year":"2020","unstructured":"Simpson S, Kaufmann MC, Glozman V, Chakrabarti A. Disease X: accelerating the development of medical countermeasures for the next pandemic. Lancet Infect Dis. 2020;20:e108\u201315. https:\/\/doi.org\/10.1016\/S1473-3099(20)30123-7.","journal-title":"Lancet Infect Dis"},{"key":"266_CR24","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1001\/jama.2020.4984","volume":"323","author":"DC Angus","year":"2020","unstructured":"Angus DC. Optimizing the trade-off between learning and doing in a pandemic. JAMA. 2020;323:1895\u20136. https:\/\/doi.org\/10.1001\/jama.2020.4984.","journal-title":"JAMA"},{"key":"266_CR25","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1371\/journal.pmed.0050067","volume":"5","author":"JP Vandenbroucke","year":"2008","unstructured":"Vandenbroucke JP. Observational research, randomised trials, and two views of medical science. PLoS Med. 2008;5:e67. https:\/\/doi.org\/10.1371\/journal.pmed.0050067.","journal-title":"PLoS Med"}],"container-title":["Journal of Public Health Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1057\/s41271-020-00266-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1057\/s41271-020-00266-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1057\/s41271-020-00266-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T13:08:11Z","timestamp":1616159291000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1057\/s41271-020-00266-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["266"],"URL":"https:\/\/doi.org\/10.1057\/s41271-020-00266-7","relation":{},"ISSN":["0197-5897","1745-655X"],"issn-type":[{"value":"0197-5897","type":"print"},{"value":"1745-655X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,2]]},"assertion":[{"value":"28 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author states there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}